SEC Form D private-offering filing

Navega Therapeutics, Inc.

Name: Navega Therapeutics, Inc. - new SEC Form D private-offering filing, San Diego, CA
Published: 2026-01-30

A new SEC Form D private-offering notice from San Diego, CA, a $2,500,000 filer-stated offering target in Biotech. The source filing is one click away.

Navega Therapeutics, Inc. site↗ Verified via SEC Form D

Preclinical biotech developing non-opioid gene therapies for chronic pain using zinc finger and CRISPR based epigenome regulation

Filed 2026-01-30Filed to raise $2,500,000First money in 2026-01-02Raised so far $1,300,000HQ (as filed) San Diego, CASector Biotech ✓Stage (inferred) SeedCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified navegatx.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.